Skip to content

Cognitive Behavioral Therapy (CBT) for Nightmares in Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans

CBT for Nightmares in OEF/OIF Veterans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00691626
Enrollment
108
Registered
2008-06-05
Start date
2009-04-01
Completion date
2019-12-31
Last updated
2020-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nightmares, Posttraumatic Stress Disorder, Sleep Disorders

Keywords

posttraumatic stress, nightmares, sleep, psychotherapy, imagery rehearsal, insomnia, behavioral treatment, veterans, Operation Iraqi Freedom, Operation Enduring Freedom

Brief summary

The purpose of this study is to compare the effectiveness of two talk therapies for OEF/OIF Veterans at the Michael J. Crescenz and the West Haven VA Medical Centers. Participants will randomly receive one of two individual treatments intended to improve the sleep disturbance and nightmares of returning Veterans.

Detailed description

This is a dismantling study with the objective of determining whether imagery rehearsal is essential to the efficacy of imagery rehearsal + CBT-I for improving the sleep and nightmare disturbance in Veterans with PTSD and recurrent nightmares.

Interventions

BEHAVIORALCBT for Insomnia plus Imagery Rehearsal

patients receive standard CBT for insomnia and psychoeducation combined with techniques of imagery rehearsal aimed at reducing posttraumatic nightmare frequency and distress

BEHAVIORALCBT for Insomnia plus psychoeducation

patients receive standard CBT for insomnia combined with psychoeducation

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Intervention model description

This is a randomized controlled trial comparing two forms of psychotherapy.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Currently enrolled in treatment in the Michael J. Crescenz VA Medical Center or VA Connecticut Healthcare System Mental Health Clinic * Meets DSM-IV-R criteria for current PTSD (within the past month) * Repetitive, military-related nightmares (at least 1 every 2 weeks, for at least 6 months) * A global sleep disturbance, as indicated by a score of five or greater on the Pittsburgh Sleep Quality Index * Ability to read and speak English * A concurrent anxiety disorder or depressive disorder diagnosis will be allowed * Dementia related to head injury and amnestic disorder related to head injury will be allowed

Exclusion criteria

* Current substance dependence * Bipolar disorder * Delirium * Dementia that is not related to head injury * Amnestic disorder that is not related to head injury * Schizophrenia and other psychotic disorders * Severe traumatic brain injury, as indicated by self-report (loss of consciousness or alteration of mental status greater than 24 hours, or peri-traumatic memory loss, or any posttraumatic amnesia greater than 7 days) * The presence of diagnosed sleep disorders other than insomnia: narcolepsy, circadian rhythm sleep disorders, and periodic limb movement disorder. Participants in treatment for sleep apnea, or who have not benefited from or declined available treatment may be included.

Design outcomes

Primary

MeasureTime frameDescription
Nightmare Frequency Questionnaire, Nightmare Distress Questionnairepost-treatment, 3 month and 6-month follow-upThe NFQ measures the number of nightmares/week and the number of nights with a nightmare/week. The NDQ measures the distress associated with nightmare experiences.

Secondary

MeasureTime frameDescription
Pittsburgh Sleep Quality Indexpost-treatment, 3 month and 6-month follow-upThis is a standard instrument for measuring basic sleep parameters.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026